• Notes for this agenda item

• Type your task here. Use "@" to assign a user and "//" to select a due date.

1. Histologic type of neoplasm of X (64 new observable entities)
2. Histologic grade of neoplasm of X (81 concepts)
3. Anatomic locations invaded by neoplasm of X (90)
4. Perineural and Lymphovascular invasion (63)
5. Lymph node concepts (22)
6. Surgical margins involved by neoplasm of X (50)
7. Dimension concepts (50)

1. Surgical margins (presence of involvement) moved to review (190+ concepts)

1. How to reflect margins that reference anatomical location 
2. JCA will allow editorial exception for anatomic structure in FSN of surgical margin when dictated by specific, limited cases defined by pathologists

Discuss clinical finding concepts in existing SI content.  To inactivate or not - Follow up with UK use case

1. Tumor buds and tumor deposits
2. FIGO and other stage/grades?
3. Tumor focality
4. Treatment effect
5. Depth of invasion
6. Other areas

1. ENETS
2. FIGO

I&E documents to do and review

1. How to model primary, metastatic and unknown processes in Observable entity concepts and in disorders
   
   
2. Impact on links to ICD-O-3 behavior codes
   
   
3. Impact on ICD-O-3 histology codes

Note:  primary/secondary/metastatic/unknown/post-treatment tumors discussion needs to move back to editorial advisory group.  FSN implications and definitions....more discussion needed.  

How does this impact grouper concepts